Arthneeti
Latest: Camlin Fine Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
CF

Camlin Fine

Q3 FY26Chemicals & Petrochemicals

Camlin Fine Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹109
Market cap₹2.0K Cr
Updated23 Aug 2026
Read3 min read

Camlin Fine Q3 FY26 key numbers

Revenue
Vitafor (animal feed segment) expected to grow 40%-50% in FY'27 from current top-line of €12-13 million to €17-18 million.

As stated in Camlin Fine's Q3 FY26 earnings call transcript · published 25 May 2026. Reported figures, not investment advice.

The short version

Revenue guidance for FY'27 is approximately Rs. Revenue guidance for FY'27 is approximately Rs.

From Camlin Fine's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Revenue guidance for FY'27 is approximately Rs. 2,200 crores; for FY'28, around Rs. 2,400 crores.
  • Vanillin volume guidance for FY'27 is 4,000 metric tons, indicating a growth of about 50%-60% from FY'26.
  • Blend business projected to grow by 20%-25% over FY'26, targeting around Rs. 1,350 crores in FY'27 from Rs. 1,000 crores.
  • Vitafor (animal feed segment) expected to grow 40%-50% in FY'27 from current top-line of €12-13 million to €17-18 million.

2 more points from Camlin Fine's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Camlin Fine said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Currently, no new plants are planned.
  • Maintenance CAPEX is ongoing, approximately Rs. 40-50 crores annually due to existing large plants.
  • No new CAPEX plans have been approved or are currently on the cards.

2 more points from Camlin Fine's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Camlin Fine said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company indicates strong demand growth, especially in blends and Vanillin segments.
  • They expect Vanillin sales to increase to about 4,000 tons in FY'27, up from 2,300-2,400 tons, reflecting optimism about order flow.
  • Blends segment is projected to grow 25% over FY'26.
  • The company is actively working on expanding market access, including launching new products like ethyl Vanillin and expanding in markets like the US, Europe, Brazil, and India.
  • The recent acquisition of Vinpai is expected to contribute to increasing sales and margins as volume builds.

2 more points from Camlin Fine's call on order book

Create a free account to keep reading this call

Camlin Fine — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹425 Cr, net profit ₹86 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Camlin Fine's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chem. (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Camlin Fine and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Camlin Fine Q3 FY26 results?

Revenue guidance for FY'27 is approximately Rs. Revenue guidance for FY'27 is approximately Rs.

What is Camlin Fine share price analysis?

Camlin Fine currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,993 Cr. Investors should review the full earnings analysis for detailed insights.

Is Camlin Fine planning capital expenditure?

Currently, no new plants are planned. - Maintenance CAPEX is ongoing, approximately Rs.

Keep Camlin Fine on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.